Cushing's syndrome after topical application of corticosteroids.
D000287:Administration, Topical; D001623:Betamethasone / Q000031:analogs & derivatives*; D001624:Betamethasone Valerate / Q000009:adverse effects*; D003480:Cushing Syndrome / Q000139:chemically induced*; D006801:Humans; D007223:Infant; D008297:Male; D012869:Skin Absorption
D001623:Betamethasone; D001624:Betamethasone Valerate